Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide vs. Placebo in Adults With Type 1 Diabetes and Overweight/Obesity
NCT07891156Phase 3Recruiting
- Sponsor
- McGill University Health Centre
- Start
- Oct 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in type 1 diabetes mellitus (T1D), obesity, sponsored by McGill University Health Centre. Started Oct 2026; status: recruiting.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)obesity
Beyond the preview
Go deeper on NCT07891156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891156.